Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms
Saved in:
| Published in: | EJNMMI Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms
- Dosimetry of [Lu]Lu-PSMA therapy in a hemodialysis patient: a case study
- Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE
- Need for careful endoscopic evaluation of large gastric neoplasms before endoscopic submucosal ...
- Outcome and safety of single-dose docetaxel–augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience
- Radiofluorination and biological evaluation of -aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB receptors
- Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and ...